IP Verse

Anti-Factor Xi Monoclonal Antibodies And Methods Of Use Thereof - EP3002298

The patent EP3002298 was granted to Oregon Health & Science University on Aug 28, 2019. The application was originally filed on Nov 21, 2008 under application number EP15189714A. The patent is currently recorded with a legal status of "Revoked".

EP3002298

OREGON HEALTH & SCIENCE UNIVERSITY
Application Number
EP15189714A
Filing Date
Nov 21, 2008
Status
Revoked
Mar 25, 2022
Grant Date
Aug 28, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SHARP & DOHMEApr 8, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB -

Patent Citations (31) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0075444
DESCRIPTIONEP0396387
DESCRIPTIONUS2002123057
DESCRIPTIONUS2004132101
DESCRIPTIONUS2008084336
DESCRIPTIONUS4683195
DESCRIPTIONUS4873192
DESCRIPTIONUS5116964
DESCRIPTIONUS5122464
DESCRIPTIONUS5225538
DESCRIPTIONUS5225539
DESCRIPTIONUS5314995
DESCRIPTIONUS5585089
DESCRIPTIONUS5693761
DESCRIPTIONUS5693762
DESCRIPTIONUS5859205
DESCRIPTIONUS5892019
DESCRIPTIONUS5939598
DESCRIPTIONUS6180370
DESCRIPTIONUS6737056
DESCRIPTIONWO0127160
DESCRIPTIONWO02096948
DESCRIPTIONWO2009067660
DESCRIPTIONWO8605807
DESCRIPTIONWO8901036
DESCRIPTIONWO8912624
DESCRIPTIONWO9114438
DESCRIPTIONWO9208495
DESCRIPTIONWO9314125
EXAMINATIONUS6623960
SEARCHUS2006057140

Non-Patent Literature (NPL) Citations (141) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ADV. IN DRUG DELIV. REV., (2002), vol. 54, page 531-
DESCRIPTION- AKHAVAN ET AL., THROMB. HAEMOST., (2000), vol. 84, pages 989 - 997-
DESCRIPTION- "Analysis, Results, and Future Prospective of the Therapeutic Use of Radiolabeled Antibody in Cancer Therapy", Monoclonal Antibodies for Cancer Detection and Therapy, ACADEMIC PRESS, (1985), pages 303 - 16-
DESCRIPTION- ANGLIKER ET AL., BIOCHEM J., (1988), vol. 256, pages 481 - 486-
DESCRIPTION- "Antibodies for Drug Delivery", HELLSTROM ET AL., Controlled Drug Delivery, MARCEL DEKKER, INC., (1987), pages 623 - 53-
DESCRIPTION- "Antibody Carriers of Cytotoxic Agents in Cancer Therapy: A Review", THORPE ET AL., Monoclonal Antibodies '84: Biological and Clinical Applications, (1985), pages 475 - 506-
DESCRIPTION- ASAKI ET AL., BIOCHEMISTRY, (1987), vol. 26, pages 7221 - 7228-
DESCRIPTION- BAGLIA ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 49323 - 49329-
DESCRIPTION- BAJZAR ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 16,603 - 16,608-
DESCRIPTION- BANEZ ET AL., AM. J. CLIN. PATHOL., (1980), vol. 74, pages 569 - 574-
DESCRIPTION- BEBBINGTON; HENTSCHEL, The Use of Vectors Based on Gene Amplification for the Expression of Cloned Genes in Mammalian Cells in DNA Cloning, ACADEMIC PRESS, (1987), vol. 3-
DESCRIPTION- BOERI, DIABETES, (2001), vol. 50, pages 1432 - 1439-
DESCRIPTION- BROZE ET AL., THROMB. HAEMOST., (1993), vol. 70, pages 72 - 74-
DESCRIPTION- BROZE; GAILANI, THROMB. HAEMOST., (1993), vol. 70, pages 72 - 74-
DESCRIPTION- BROZE; HIGUCHI, BLOOD, (1996), vol. 88, pages 3815 - 3823-
DESCRIPTION- CARMON, J. NEURAL. SCI., (1966), vol. 4, pages 111 - 119-
DESCRIPTION- CHOTHIA; LESK, J. MOL. BIOL., (1987), vol. 196, pages 901 - 917-
DESCRIPTION- CLINICAL PHARMACY, vol. 12, pages 488 - 505-
DESCRIPTION- COCKETT ET AL., BIO/TECHNOLOGY, (1990), vol. 8, page 2-
DESCRIPTION- COLBERRE-GARAPIN ET AL., J. MOL. BIOL., (1981), vol. 150, page 1-
DESCRIPTION- CROUSE ET AL., MOL. CELL. BIOL., (1983), vol. 3, page 257-
DESCRIPTION- Current Protocols in Immunology, JOHN WILEY & SONS-
DESCRIPTION- DALLDORF, ARCH. PATHOL. LAB. MED., (1977), vol. 101, pages 6 - 9-
DESCRIPTION- DAYHOFF ET AL., Atlas of Protein Sequence and Structure, NATL. BIOMED. RES. FOUND., (1978), pages 345 - 352-
DESCRIPTION- DENNIS, BR. J. HAEMATOL., (1969), vol. 17, pages 455 - 462-
DESCRIPTION- DE STGROTH; SCHEIDEGGER, J. IMMUNOL. METHODS, (1980), vol. 35, pages 1 - 21-
DESCRIPTION- DICHEK ET AL., CIRCULATION, (1996), vol. 93, pages 301 - 309-
DESCRIPTION- DNA Cloning, (1985), vol. I, II-
DESCRIPTION- FOECKING ET AL., GENE, (1986), vol. 45, page 101-
DESCRIPTION- FUJIKAWA ET AL., BIOCHEMISTRY, (1986), vol. 25, pages 2417 - 2424-
DESCRIPTION- GAILANI; BROZE, SCIENCE, (1991), vol. 253, pages 909 - 912-
DESCRIPTION- GAILANI ET AL., BLOOD, (2001), vol. 97, pages 3117 - 3122-
DESCRIPTION- GAILANI ET AL., SCIENCE, (1991), vol. 253, pages 909 - 912-
DESCRIPTION- GEAR, REV. INFECT. DIS., (1979), vol. 1, pages 571 - 591-
DESCRIPTION- GENTZ ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 821 - 824-
DESCRIPTION- GIRAUDON ET AL., J IMMUNOL, (2004), vol. 172, no. 2, pages 1246 - 1255-
DESCRIPTION- GRUBER ET AL., BLOOD, (1994), vol. 83, pages 2541 - 2548-
DESCRIPTION- GRUBER ET AL., BLOOD, (2003), vol. 102, pages 953 - 955-
DESCRIPTION- GRUBER ET AL., BLOOD, (2007), vol. 109, pages 3733 - 3740-
DESCRIPTION- GRUBER; HANSON, BLOOD, (2003), vol. 102, pages 953 - 955-
DESCRIPTION- Handbook Of Experimental Immunology, (1986), vol. I-IV-
DESCRIPTION- HANSON ET AL., J. CLIN. INVEST., (1985), vol. 75, pages 1591 - 1599-
DESCRIPTION- HANSON ET AL., J. CLIN. INVEST., (1988), vol. 81, pages 149 - 158-
DESCRIPTION- HANSON ET AL., J. CLIN. INVEST., (1993), vol. 92, pages 2003 - 2012-
DESCRIPTION- HANSON ET AL., PROC. NATL. ACAD. SCI. USA., (1988), vol. 85, pages 3184 - 188-
DESCRIPTION- HARLAND, LANCET, (1966), vol. 26, pages 1158 - 1160-
DESCRIPTION- HARLOW ET AL., Antibodies: A Laboratory Manual, COLD SPRING HARBOR LABORATORY PRESS, (1988), pages 27 - 28-
DESCRIPTION- Harrison's Principle of Internal Medicine, MCGRAW-MILL, (1998), page 341-
DESCRIPTION- HEMKER ET AL., PATHOPHYSIOLOGY OF HAEMOSTASIS & THROMBOSIS, (2003), vol. 33, pages 4 - 15-
DESCRIPTION- HOFFMAN; MONROE, THROMB. HAEMOST., (2001), vol. 85, pages 958 - 965-
DESCRIPTION- IGNATIEV, IMMUNOL. LETT., (2000), vol. 71, pages 131 - 140-
DESCRIPTION- INOUYE; INOUYE, NUCLEIC ACIDS RES., (1985), vol. 13, pages 3101 - 3109-
DESCRIPTION- ISHIBASHI, DIABETES, (1981), vol. 30, pages 601 - 606-
DESCRIPTION- JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525-
DESCRIPTION- JONES ET AL., NATURE, (1986), vol. 331, pages 522 - 525-
DESCRIPTION- JONES, GENETICS, (1977), vol. 85, page 12-
DESCRIPTION- KASPER ET AL., THROMB. DIATH. HAEMORRH., (1975), vol. 34, pages 869 - 872-
DESCRIPTION- KATO ET AL., CYTOGENET. CELL GENET., (1989), vol. 52, page 77-
DESCRIPTION- KAWASAKI ET AL., ANESTHESIA & ANALGESIA, (2004), vol. 99, pages 1440 - 1444-
DESCRIPTION- KINGSMAN ET AL., GENE, (1979), vol. 7, page 141-
DESCRIPTION- KUMANOGOH ET AL., J IMMUNOL, (2002), vol. 169, pages 1175 - 1181-
DESCRIPTION- KUNKEL ET AL., METHODS ENZYMOL., (1987), vol. 154, pages 367 - 382-
DESCRIPTION- KUNKEL, PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 488 - 492-
DESCRIPTION- KUTMEIER ET AL., BIOTECHNIQUES, (1994), vol. 17, page 242-
DESCRIPTION- LEONG ET AL., CYTOKINE, (2001), vol. 16, page 106-
DESCRIPTION- LOWY ET AL., CELL, (1980), vol. 22, page 817-
DESCRIPTION- LUSHER ET AL., N. ENGL. J. MED., (1980), vol. 303, pages 421 - 425-
DESCRIPTION- "Mammalian Expression Vectors", RIDGWAY, Vectors, BUTTERWORTHS, (1988), pages 470 - 472-
DESCRIPTION- MARKOU ET AL., Annals Biomed. Engineering, (1998), vol. 26, pages 502 - 511-
DESCRIPTION- MCCARTY ET AL., J. THROMB. HAEMOST., (2006), vol. 4, pages 1367 - 1378-
DESCRIPTION- MCCUTCHEON, LUPUS, (1993), vol. 2, pages 99 - 103-
DESCRIPTION- MEADOWS, MED. J. AUST., (1965), vol. 4, pages 409 - 411-
DESCRIPTION- Methods In Enzymology, ACADEMIC PRESS, INC.-
DESCRIPTION- Methods In Enzymology, vol. 154, 155-
DESCRIPTION- MILLER, KIDNEY INT., (1980), vol. 18, pages 472 - 479-
DESCRIPTION- MINNEMA ET AL., J. CLIN. INVEST., (1988), vol. 101, pages 10 - 14-
DESCRIPTION- "Monoclonal Antibodies for Immunotargeting of Drugs in Cancer Therapy", ARNON ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, INC., (1985), pages 243 - 56-
DESCRIPTION- MORGAN; ANDERSON, ANN. REV. BIOCHEM., (1993), vol. 62, pages 191 - 217-
DESCRIPTION- MULLIGAN; BERG, PROC. NATL. ACAD. SCI. USA, (1981), vol. 78, page 2072-
DESCRIPTION- MULLIGAN, SCIENCE, (1993), vol. 260, pages 926 - 932-
DESCRIPTION- NAGASHIMA ET AL., J. CLIN. INVEST., (2002), vol. 109, pages 101 - 110-
DESCRIPTION- NEGRIER ET AL., THROMB. HAEMOST., (1997), vol. 77, pages 1113 - 1119-
DESCRIPTION- NENCI ET AL., BLOOD COAGUL. FIBRINOLYSIS, (1992), vol. 3, pages 279 - 285-
DESCRIPTION- NISHIYA ET AL., BLOOD, (2002), vol. 100, pages 136 - 142-
DESCRIPTION- O'HARE ET AL., PROC. NATL. ACAD. SCI. USA, (1981), vol. 78, page 1527-
DESCRIPTION- PAYNE ET AL., J. VASE. SURG., (2002), vol. 35, pages 1204 - 1209-
DESCRIPTION- PEDICORD ET AL., PNAS USA, (2007), vol. 104, pages 12,855 - 12,860-
DESCRIPTION- PRESTA, CURR. OP. STRUCT. BIOL., (1992), vol. 2, pages 593 - 596-
DESCRIPTION- PROCTOR ET AL., AM. J. CLIN. PATHOL., (1961), vol. 36, pages 212 - 219-
DESCRIPTION- RENNE ET AL., J. EXP. MED., (2005), vol. 202, pages 271 - 281-
DESCRIPTION- RHODES, SURG. GYNECOL. OBSTET., (1973), vol. 136, pages 409 - 416-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 329-
DESCRIPTION- ROSEN ET AL., THROMB. HAEMOST., (2002), vol. 87, pages 774 - 776-
DESCRIPTION- RUTHER ET AL., EMBO J., (1983), vol. 2, page 1791-
DESCRIPTION- SANTERRE ET AL., GENE, (1984), vol. 30, page 147-
DESCRIPTION- SAVAGE ET AL., BLOOD, (1986), vol. 68, pages 386 - 393-
DESCRIPTION- SCHARRER, HAEMOPHILIA, (1999), vol. 5, pages 253 - 259-
DESCRIPTION- SHAPIRO ET AL., THROMB. HAEMOST., (1998), vol. 80, pages 773 - 778-
DESCRIPTION- SHI ET AL., IMMUNITY, (2000), vol. 13, pages 633 - 642-
DESCRIPTION- SJAMSOEDIN ET AL., N. ENGL. J. MED., (1981), vol. 305, pages 717 - 21-
DESCRIPTION- SMITH ET AL., AM. J. CLIN. PATHOL., (1985), vol. 83, pages 211 - 215-
DESCRIPTION- SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489-
DESCRIPTION- STINCHCOMB ET AL., NATURE, (1979), vol. 282, page 39-
DESCRIPTION- SUNDELL ET AL., CIRCULATION, (1997), vol. 96, pages 941 - 948-
DESCRIPTION- SUN ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 29,023 - 29,028-
DESCRIPTION- SUN ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 36373 - 36378-
DESCRIPTION- SUN, Y.; GAILANI, D., J. BIOL. CHEM., (1996), vol. 271, pages 29023 - 29028-
DESCRIPTION- SZYBALSKA; SZYBALSKI, PROC. NATL. ACAD. SCI. USA, (1992), vol. 48, page 202-
DESCRIPTION- THORPE ET AL., "The Preparation and Cytotoxic Properties of Antibody-Toxin Conjugates", IMMUNOL. REV., (1982), vol. 62, pages 119 - 58-
DESCRIPTION- TIB TECH, (199305), vol. 11, no. 5, pages 155 - 215-
DESCRIPTION- TOLSTOSHEV, ANN. REV. PHARMACOL. TOXICOL., (1993), vol. 32, pages 573 - 596-
DESCRIPTION- TSCHEMPER ET AL., GENE, (1980), vol. 10, page 157-
DESCRIPTION- VAN DEN BESSELAAR ET AL., THROMB. HAEMOST., (1990), vol. 63, pages 16 - 23-
DESCRIPTION- VAN HEEKE; SCHUSTER, J. BIOL. CHEM., (1989), vol. 24, pages 5503 - 5509-
DESCRIPTION- VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536-
DESCRIPTION- WANG ET AL., BLOOD, (2001), vol. 97, pages 3498 - 3504-
DESCRIPTION- WANG ET AL., J. THROMB. HAEMOST., (2005), vol. 3, pages 695 - 702-
DESCRIPTION- WANG ET AL., J. THROMB. HAEMOST., vol. 4, pages 1982 - 1988-
DESCRIPTION- WATANABE ET AL., J IMMUNOL, (2001), vol. 167, pages 4321 - 4328-
DESCRIPTION- WEIR ET AL., BIOCHEM. SOC. TRANSACTIONS, (2002), vol. 30, page 512-
DESCRIPTION- WIGLER ET AL., CELL, (1977), vol. 11, page 223-
DESCRIPTION- WIGLER ET AL., NATL. ACAD. SCI. USA, (1980), vol. 77, page 357-
DESCRIPTION- WILSON ET AL., CELL, (1984), vol. 37, page 767-
DESCRIPTION- WU; WU, BIOTHERAPY, (1991), vol. 3, pages 87 - 95-
DESCRIPTION- XI ET AL., THROMB. HAEMOST., (1989), vol. 62, pages 788 - 791-
DESCRIPTION- XU ET AL., BIORHEOLOGY, (2004), vol. 41, pages 113 - 125-
DESCRIPTION- YUN ET AL., J. BIOL. CHEM., (2003), vol. 48, pages 48112 - 48119-
EXAMINATION- HO DAVID H ET AL, "A binding site for heparin in the Apple 3 domain of factor XI", JOURNAL OF BIOLOGICAL CHEMISTRY, (19980626), vol. 273, no. 26, ISSN 0021-9258, pages 16382 - 16390-
EXAMINATION- LEE JAE KOO ET AL, "Development of an ELISA for the detection of the residues of the insecticide imidacloprid in agricultural and environmental samples", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, (200105), vol. 49, no. 5, ISSN 0021-8561, pages 2159 - 2167-
EXAMINATION- MOHAMMED BASSEM M ET AL, "An update on factor XI structure and function", THROMBOSIS RESEARCH, (201801), vol. 161, ISSN 0049-3848, pages 94 - 105-
EXAMINATION- OROSZ FERENC ET AL, "A simple method for the determination of dissociation constants by displacement ELISA.", JOURNAL OF IMMUNOLOGICAL METHODS, (20021215), vol. 270, no. 2, ISSN 0022-1759, pages 155 - 162-
EXAMINATION- PEDICORD DONNA L ET AL, "Feedback activation of factor XI by thrombin does not occur in plasma", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200707), vol. 104, no. 31, ISSN 0027-8424, pages 12855 - 12860-
EXAMINATION- PUY CRISTINA ET AL, "The hemostatic role of factor XI", THROMBOSIS RESEARCH, (201605), vol. 141, no. Suppl. 2, ISSN 0049-3848, pages S8 - S11-
EXAMINATION- RENNE THOMAS ET AL, "Characterization of the H-kininogen-binding site on factor XI. A comparison of factor XI and plasma prekallikrein", JOURNAL OF BIOLOGICAL CHEMISTRY, (20020215), vol. 277, no. 7, ISSN 0021-9258, pages 4892 - 4899-
EXAMINATION- ZHAO MINGMING ET AL, "Characterization of a heparin binding site on the heavy chain of factor XI", JOURNAL OF BIOLOGICAL CHEMISTRY, (19981120), vol. 273, no. 47, ISSN 0021-9258, pages 31153 - 31159-
SEARCH- GRUBER ANDRAS ET AL, "Antithrombotic factor XI antibody inhibition of the intrinsic pathway", BLOOD, & 43RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, PART 1; ORLANDO, FLORIDA, USA; DECEMBER 07-11, 2001, (20011116), vol. 98, no. 11 Part 1, ISSN 0006-4971, page 42a, XP009116110 [A] 1-15 * the whole document *-
SEARCH- TUCKER ERIK I ET AL, "Inhibition of factor XI decreases thrombin production and prevents vascular occlusion in experimental thrombosis in primates", BLOOD, & 49TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 08 -11, 2007, (20071116), vol. 110, no. 11, Part 1, ISSN 0006-4971, page 235A, XP009116108 [A] 1-15 * the whole document *-
SEARCH- SUN YUEHUI ET AL, "Identification of a factor IX binding site on the third apple domain of activated factor XI", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, (19960101), vol. 271, no. 46, ISSN 0021-9258, pages 29023 - 29028, XP002435764 [X] 1,2,8-10 * abstract * * page 29026, column r, paragraph 2 * * page 29024, column l, paragraph 3 * [I] 3,11-15
SEARCH- GRUBER ANDRAS ET AL, "Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates.", BLOOD, (20030801), vol. 102, no. 3, ISSN 0006-4971, pages 953 - 955, XP002526372 [A] 1-15 * abstract * * page 953, column r, paragraph 2 *
SEARCH- TUCKER ERIK I ET AL, "Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, UNITED STATES, (20090122), vol. 113, no. 4, doi:10.1182/BLOOD-2008-06-163675, ISSN 1528-0020, pages 936 - 944, XP009116109 [IP] 1-15 * page 937, column r, paragraph 3 * * paragraph bridging pages 937/938; page 937 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents